[A case of interstitial pneumonitis induced by S-1].
Gan To Kagaku Ryoho
; 37(8): 1603-6, 2010 Aug.
Article
in Ja
| MEDLINE
| ID: mdl-20716897
ABSTRACT
S-1, an oral fluoropyrimidine derivative, has been identified as an effective agent for the treatment of breast cancer. We present here a case of interstitial pneumonitis that occurred after S-1 treatment. A n 80-year-old woman was diagnosed with stage III infiltrating ductal carcinoma of the left breast and underwent a modified radical mastectomy in November 2001, followed by six courses of paclitaxel. In October 2008, metastatic disease was detected in her skeletal system. Therefore, S-1 chemotherapy was initiated (100 mg/body). Five days after starting S-1, she developed severe eruptions along with dyspnea. X-rays and CT scan showed diffuse ground glass shadow. Both her symptoms and the radiographic findings resolved dramatically after the start of high-dose corticosteroid therapy. Clinicians should be aware that S-1 has the potential to cause lung injury when it is included in chemotherapy.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oxonic Acid
/
Tegafur
/
Lung Diseases, Interstitial
Type of study:
Prognostic_studies
Limits:
Aged80
/
Female
/
Humans
Language:
Ja
Journal:
Gan To Kagaku Ryoho
Year:
2010
Document type:
Article